Carry-over effects in GAG therapy efficacy trial solution for bladder pain syndrome/interstitial cystitis (GETSBI study): an interim analysis.

BMJ Open · 2025 · PMC12142162 · PMID 40473282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The measured carry-over effect was 0.50 points on the VAS pain (95% CI −1.17 to 2.17), which did not reach statistical significance and was on the verge of clinical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.